AEMD stock: buy or sell?

AEMD stock price: $0.40 -4.76% At close on May 21st, 2019

Updated on:
May 21st, 2019

0

Aethlon Medical plummed a bloodcurdling -4.76% and closed at $0.40. On Wednesday AEMD collapsed a chilling -24.44%. On May 14th AEMD boosted an amazing 16.07%.

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide.

Should I buy AEMD stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Aethlon Medical stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean AEMD will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Aethlon Medical stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for AEMD stock for the last month.

AEMD stock analysis

Daily outlook

Aethlon Medical shares plummed -4.76% to $0.40 today.

Aethlon Medical shares plummed -4.76% to $0.40 today. Since price and SMA200d lines crossed down on February, AEMD fell $-0.97 per share (-70.80%). AEMD marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $0.85 would break this short term down trend and open possibilities for reversing this situation.

AEMD stock chart (daily)

Weekly outlook

After sliding a chilling -14.29% in a week last week, Aethlon Medical closed this week at $0.40 and plummed a godawful -4.76%. This was the fourth red week in a row, sliding in full a -49.30%. Late April AEMD climbed a superb 5.33% in just one week.

Aethlon Medical is now in fresh lows to find new supports after falling under the support. Since price and 40-weeks moving average lines crossed down by mid February, AEMD fell $-0.96 per share (-70.59%). Stocks under the 200 days moving average line are usually not recommended for average traders.

AEMD stock chart (weekly)

AEMD stock price history

AEMD IPO was on February 11th, 2002 at $65.00 per share1. Since then, AEMD stock sliced a -99.40%, with a yearly average of -5.80%.

1: Adjusted price after possible price splits or reverse-splits.

AEMD stock historical price chart

AEMD stock reached 52-week highs on November at $1.74, and all-time highs 2004-03-09 with a price of 212.5.

AEMD stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' AEMD stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price forecast for Aethlon Medical stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Aethlon Medical reported super good results for 2018-Q4 on February. Aethlon Medical climbed Earnings per Share (EPS) by 57.10%, beating analysts estimates of $-0.07. Aethlon Medical posted $-0.11.
AEMD earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.22n/a
2017-Q2-n/a-0.17n/a
2017-Q32017-11-02n/an/an/a
2017-Q42018-02-09-0.11-0.08n/a
2018-Q12018-06-08-0.1-0.06n/a
2018-Q22018-08-08-0.08-0.06n/a
2018-Q32018-11-06-0.07-0.08n/a
2018-Q42019-02-11-0.07-0.11n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to 2017, last anual sales report draw a frightening slide of -61.84% to $0.15 M dollars. Similarly, its profit margin (compared to revenues) plummed to -3,795.86%, that is $-5.68 million.

To have an up to date view of the financial situation of Aethlon Medical, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q4 that can be compared to 2018 fiscal year results. Annual Aethlon Medical TTM sales up to December 2018 were $0.22 and income was $-5.87 million dollars. If we compare this TTM figures with the last reported annuality, we can esteem Aethlon Medical business evolution since March 2018: Annual sales up to December, compared to lastest yearly report, rocketed an extraordinary 50.00%. In line, profit margin (net income/revenues) skyrocketed at -3,795.86%.

AEMD annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$1.23 M-$-4.89 M-397.6%-
2014$1.62 M31.71%$-13.36 M-824.7%173.21%
2015$0.76 M-52.94%$-6.80 M-891.5%-49.12%
2016$0.89 M16.28%$-4.87 M-549.6%-28.32%
2017$0.39 M-55.78%$-7.28 M-1855.8%49.34%
2018$0.15 M-61.84%$-5.68 M-3795.9%-21.94%
TTM $0.22 M50.00%$-5.87 M-2616.1%3.38%

Quarterly financial results

Reported quarter earnings marked $-2.01 M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Aethlon Medical sales marked a hair-raising loss and collapsed a -100.00%. Looking back to recent quarterly results, Aethlon Medical posted 2 negative quarters in a row.
AEMD quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q4$0.07 M-$-1.22 M-1624.1%-
2018-Q1$0.07 M0.00%$-1.32 M-1762.9%8.55%
2018-Q2$0.15 M100.00%$-1.15 M-766.1%-13.09%

Aethlon Medical ownership

When you are planning to buy shares of a company, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Aethlon Medical, 6.64% of all outstanding shares are owned by its staff.

In case of Aethlon Medical stock, 14.95% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AEMD stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related stocks:

AEMDAXDXBASIBRKRCOHR
Market cap$7.6 M$1.0 B$19.6 M$6.5 B$2.9 B
Total shares19.0 M54.5 M10.5 M156.8 M24.2 M
Float shares17.7 M26.6 M6.9 M103.2 M23.9 M
  - Institutional holdings (%)14.9%50.2%12.3%68.7%101.1%
  - Insider holdings (%)6.6%46.2%28.6%34.4%1.2%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

AEMD summary

Tuesday, May 21st, 2019
Open$0.42
Close$0.40
Day range$0.38 - $0.43
Previous close$0.42
Session gain-4.76%
Average true range$0.09
50d mov avg$0.79
100d mov avg$1.02
200d mov avg$1.09
Daily patternlb06a
Weekly pattern lt01c

Aethlon Medical performance

To measure stock performance is always good to benchmark with competitors or related stocks. For Aethlon Medical, the comparison is made against Accelerate Diagnostics, Bioanalytical Systems, Bruker, Coherent, Inovio Pharmaceuticals, Pacific Biosciences of California and PerkinElmer.
Stock3m6m12m
AEMDAethlon Medical-60.40%-68.00%-66.94%
AXDXAccelerate Diagno...-12.52%41.26%-5.50%
BASIBioanalytical Sys...24.67%39.55%16.15%
BRKRBruker10.33%30.75%37.80%
COHRCoherent-11.03%-5.01%-30.19%
INOInovio Pharmaceut...-11.26%-35.98%-32.45%
PACBPacific Bioscienc...-5.29%-7.06%175.89%
PKIPerkinElmer-8.59%4.83%15.39%

Aethlon Medical competitors

One check before investing in any stock is to have a look a list of its competitors, in this case for Aethlon Medical. We selected 7 companies as Aethlon Medical competitors as they are in the same industry or have similar market objectives.